Insider filing · BBNX
Mike Mensinger
Chief Product Officer
profile →
Beta Bionics, Inc.
BBNX · Healthcare · 15 filings in 24 months
ticker →
Mike Mensinger bought $567K of Beta Bionics (BBNX)
Executed Jan 31 2025, disclosed Feb 3 2025, 3 days later.
Value, as filed
$567K
33,350 sh × $17.00
Executed
Jan 31 2025
the trade date, as filed
Disclosed
Feb 3 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
-23.0%
-10.7% from execution
Over the 21 trading sessions from the disclosed entry session (Feb 3 2025), the stock returned -23.0% (delay-adjusted); from the execution session (Jan 31 2025), -10.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
MMMike Mensinger (Chief Product Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Beta Bionics, Inc. (BBNX). The largest single filing was $213K of BBNX (7,200 sh × $29.56, as filed), executed Jan 2.
The name
BBNXHealthcare · Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to en…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mike Mensinger in BBNX
BBNXSALE
Beta Bionics, Inc.
$213K7,200 sh × $29.56
Exec Jan 2
Filed Jan 5 · 5:30 PM ET